ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 166 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,735,000 | -32.0% | 113,600 | 0.0% | 0.07% | -40.0% |
| Q1 2018 | $2,553,000 | -74.7% | 113,600 | -66.1% | 0.12% | -77.1% |
| Q4 2017 | $10,078,000 | -20.1% | 334,700 | 0.0% | 0.52% | -26.6% |
| Q3 2017 | $12,608,000 | +35.1% | 334,700 | 0.0% | 0.72% | +23.1% |
| Q2 2017 | $9,335,000 | -18.9% | 334,700 | 0.0% | 0.58% | -23.8% |
| Q1 2017 | $11,507,000 | +19.2% | 334,700 | 0.0% | 0.76% | +21.3% |
| Q4 2016 | $9,653,000 | -9.3% | 334,700 | 0.0% | 0.63% | -3.4% |
| Q3 2016 | $10,647,000 | -2.0% | 334,700 | 0.0% | 0.65% | -2.3% |
| Q2 2016 | $10,864,000 | +16.1% | 334,700 | 0.0% | 0.66% | +27.2% |
| Q1 2016 | $9,358,000 | -21.6% | 334,700 | 0.0% | 0.52% | -12.2% |
| Q4 2015 | $11,932,000 | +10.4% | 334,700 | +2.4% | 0.60% | -5.1% |
| Q3 2015 | $10,804,000 | -4.8% | 326,700 | +20.5% | 0.63% | +2.3% |
| Q2 2015 | $11,354,000 | +28.5% | 271,100 | 0.0% | 0.61% | -7.7% |
| Q1 2015 | $8,835,000 | -34.2% | 271,100 | -35.9% | 0.66% | -54.7% |
| Q4 2014 | $13,437,000 | +28.2% | 423,200 | 0.0% | 1.47% | +0.3% |
| Q3 2014 | $10,478,000 | +9.6% | 423,200 | 0.0% | 1.46% | +12.5% |
| Q2 2014 | $9,560,000 | +103.1% | 423,200 | +118.7% | 1.30% | +77.8% |
| Q1 2014 | $4,708,000 | +7.4% | 193,500 | +10.3% | 0.73% | -45.9% |
| Q4 2013 | $4,383,000 | – | 175,400 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |